For a newly diagnosed hypertension patient, use a structured, stepwise approach:
1) Confirm the diagnosis first
Do not treat from a single clinic reading unless very high or symptomatic.
- Proper office technique: seated 5 min, correct cuff, average at least 2 readings on at least 2 visits
- Confirm with out-of-office BP if possible:
- Home BP monitoring (HBPM) or
- 24-hour ambulatory BP monitoring (ABPM)
- Rule out:
- White-coat hypertension
- Masked hypertension
2) Initial evaluation at diagnosis
Goals: assess CV risk, target-organ damage, secondary causes, and baseline before therapy.
History/exam
- Duration, family history, smoking, alcohol, salt, obesity, sleep apnea symptoms
- Drug causes: NSAIDs, steroids, OCPs, decongestants, stimulants, licorice, etc.
- Comorbidities: diabetes, CKD, CVD, stroke, pregnancy
Baseline tests
- Serum creatinine/eGFR, electrolytes (Na/K), glucose or HbA1c
- Lipid profile
- Urinalysis + urine albumin/protein (albumin-creatinine ratio if available)
- CBC
- ECG (± echocardiography if indicated)
- TSH and uric acid often considered depending on setting/guideline
- Fundus exam if severe/longstanding HTN suspected
3) Define BP goal and when to start medication
General practical targets (most adults):
- Target <130/80 mmHg if tolerated (common ACC/AHA-oriented practice)
- In frail elderly, individualize to avoid orthostatic symptoms/falls
Start drugs:
- Stage 1 HTN (130-139/80-89): start meds if clinical CVD, CKD, diabetes, or high 10-year CV risk; otherwise lifestyle first and reassess
- Stage 2 HTN (≥140/90): usually start pharmacotherapy plus lifestyle
4) Lifestyle treatment for everyone
- Weight reduction
- DASH-style diet
- Sodium restriction (roughly <1.5-2 g sodium/day if feasible)
- Regular aerobic + resistance exercise
- Limit alcohol
- Stop smoking
- Improve sleep, treat OSA if present
These can lower systolic BP meaningfully and improve drug response.
5) First-line drug choices
Preferred first-line classes:
- Thiazide/thiazide-like diuretic (chlorthalidone/indapamide often preferred)
- ACE inhibitor or ARB
- Long-acting dihydropyridine CCB (e.g., amlodipine)
Notes:
- Avoid ACEi + ARB combination
- Beta-blockers are not first-line unless specific indication (CAD, HF, arrhythmia, etc.)
- In Black patients (without CKD/proteinuria), CCB or thiazide often effective first choices
- In CKD with albuminuria, ACEi/ARB favored
6) Monotherapy vs initial combination
- If BP is >20/10 mmHg above target (for many patients, around ≥150/90 when target <130/80), start 2 drugs from different first-line classes, often as a single-pill combination
- Otherwise start one agent and titrate/add second agent in 4-6 weeks if not at goal
7) Follow-up and titration
- Recheck in about 1 month after starting/changing meds
- Encourage HBPM with logs
- Titrate dose or add next first-line agent until controlled
- Once controlled, follow every 3-6 months
Lab monitoring
- After ACEi/ARB/diuretic initiation or dose increase, check creatinine and potassium in 1-2 weeks
8) When to suspect secondary hypertension
Investigate if:
- Onset <30 years (without obesity/family history)
- Abrupt/severe onset or resistant HTN
- Hypokalemia, renal dysfunction, episodic headaches/palpitations/sweating
- Renal bruit, OSA features, endocrine clues
9) Hypertensive urgency/emergency red flags
Immediate referral if very high BP with acute target-organ injury symptoms/signs:
- Neurologic deficits, chest pain, pulmonary edema, acute kidney injury, visual loss, encephalopathy
Practical starter regimen examples
- Typical uncomplicated patient: amlodipine 5 mg daily OR ARB low dose
- If stage 2: ARB + amlodipine (single-pill combo if available)
- If edema/volume-sensitive: include thiazide-like diuretic
If you want, I can give a one-page clinic protocol (first visit orders, exact drug starting doses, and 1-month titration plan).